Journal of Neurology

, Volume 255, Issue 3, pp 367–370

A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease

  • B. Herting
  • S. Schulze
  • H. Reichmann
  • A. Haehner
  • T. Hummel


Olfactory function is diminished in patients with idiopathic Parkinson disease (IPD). Because previous work almost exclusively relied upon cross-sectional studies, the present investigation aimed to address the correlation between olfactory loss and duration of disease within the context of a longitudinal study, accompanying well-diagnosed patients over an average period of 4.4 years. A group of 27 IPD patients was examined (5 women, 22 men; age range 27–64 years; duration of disease: 0 to 19 years). Psychophysical olfactory testing was performed after 3–6 years (mean 4.4 years) using the "Sniffin’ Sticks" test battery which consists of subtests for odor thresholds, odor discrimination, and odor identification. The study yielded the following major results: (1) olfactory function in IPD patients changes in an unpredictable manner, (2) especially when considering results from the second session relatively few IPD patients were completely anosmic; none of the patients, however, were normosmic. One possible explanation for these findings may lie in the hypothesis based on results by Huisman et al. (2004) who reported an increase of dopaminergic neurons in the olfactory bulb in IPD patients. In this scenario, olfactory loss seen early in the disease may be based on an incomplete inhibition of olfactory input at the level of the olfactory bulb.

Key words

smell olfaction neurodegeneration 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ansari KA, Johnson A (1975) Olfactory function in patients with Parkinson's disease. J Chron Dis 28:493–497PubMedCrossRefGoogle Scholar
  2. 2.
    Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197–211PubMedCrossRefGoogle Scholar
  3. 3.
    Braak H, Rub U, Del Tredici K (2006) Cognitive decline correlates with neuropathological stage in Parkinson's disease. J Neurol Sci 248:255–258PubMedCrossRefGoogle Scholar
  4. 4.
    Doty RL, Deems D, Steller S (1988) Olfactory dysfunction in Parkinson's disease: A general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38:1237–1244PubMedGoogle Scholar
  5. 5.
    Doty RL, Laing DG (2003) Psychophysical measurement of human olfactory function, including odorant mixture assessment. In: Doty RL (ed) Handbook of olfaction and gustation, 2nd Ed. Marcel Dekker, New York, pp 203–228Google Scholar
  6. 6.
    Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI (1992) Bilateral olfactory dysfunction in early-stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 55:138–142PubMedGoogle Scholar
  7. 7.
    Galvin JE (2006) Cognitive change in Parkinson disease. Alzheimer Dis Assoc Disord 20:302–310PubMedCrossRefGoogle Scholar
  8. 8.
    Gudziol V, Lötsch J, Haehner A, Zahnert T, Hummel T (2006) Clinical significance of results from olfactory testing. Laryngoscope 116:1858–1863PubMedCrossRefGoogle Scholar
  9. 9.
    Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H (2007) Olfactory loss may be a first sign of idiopathic Parkinson's disease. Mov Disorders Mar 13; [Epub ahead of print]Google Scholar
  10. 10.
    Hawkes CH, Shephard BC, Daniel SE (1999) Is Parkinson's disease a primary olfactory disorder? Qjm 92:473–480PubMedCrossRefGoogle Scholar
  11. 11.
    Hawkes CH, Shephard BC, Daniel SE (1997) Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 62:436–446PubMedCrossRefGoogle Scholar
  12. 12.
    Huisman E, Uylings HB, Hoogland PV (2004) A 100 % increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Mov Disord 19:687–692PubMedCrossRefGoogle Scholar
  13. 13.
    Hummel T (1999) Olfactory evoked potentials as a tool to measure progression of Parkinson's Disease. In: Chase T, Bedard P (eds) Focus on Medicine Vol. 14 – New developments in the drug therapy of Parkinson’s disease. Blackwell Science, Oxford, pp 47–53Google Scholar
  14. 14.
    Hummel T, Sekinger B, Wolf S, Pauli E, Kobal G (1997) "Sniffin' Sticks": Olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 22:39–52PubMedCrossRefGoogle Scholar
  15. 15.
    Kobal G, Klimek L, Wolfensberger M, Gudziol H, Temmel A, Owen CM, Seeber H, Pauli E, Hummel T (2000) Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arch Otorhinolaryngol 257:205–211PubMedCrossRefGoogle Scholar
  16. 16.
    Mueller A, Abolmaali ND, Hakimi AR, Gloeckler T, Herting B, Reichmann H, Hummel T (2005) Olfactory bulb volumes in patients with idiopathic Parkinson's disease – a pilot study. J Neural Transm 112:1363–1370PubMedCrossRefGoogle Scholar
  17. 17.
    Muller A, Mungersdorf M, Reichmann H, Strehle G, Hummel T (2002) Olfactory function in Parkinsonian syndromes. J Clin Neurosci 9:521–524PubMedCrossRefGoogle Scholar
  18. 18.
    Pearce RK, Hawkes CH, Daniel SE (1995) The anterior olfactory nucleus in Parkinson's disease. Mov Disord 10: 283–287PubMedCrossRefGoogle Scholar
  19. 19.
    Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters EC, Berendse HW (2004) Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 56:173–181PubMedCrossRefGoogle Scholar
  20. 20.
    Quinn NP, Rossor MN, Marsden CD (1987) Olfactory threshold in Parkinson's disease. J Neurol Neurosurg Psychiatry 50:88–89PubMedGoogle Scholar
  21. 21.
    Scherfler C, Schocke MF, Seppi K, Esterhammer R, Brenneis C, Jaschke W, Wenning GK, Poewe W (2006) Voxelwise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease. Brain 129:538–542PubMedCrossRefGoogle Scholar
  22. 22.
    Stern MB, Doty RL, Dotti M, Corcoran P, Crawford D, McKeown DA, Adler C, Gollomp S, Hurtig H (1994) Olfactory function in Parkinson's disease subtypes. Neurology 44:266–268PubMedGoogle Scholar
  23. 23.
    Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarch B, Stoof JC, Wolters EC (2001) Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov Disord 16:41–46PubMedCrossRefGoogle Scholar
  24. 24.
    Westermann B, Wattendorf E, Schwerdtfeger U, Husner A, Fuhr P, Gratzl O, Wolfensberger M, Hummel T, Bilecen D, Welge-Lüssen A (2007) Functional modulation of cortical olfactory pathways in Parkinson's disease: An fMRI study. J Neurol Neurosurg Psychiatry May 22 (Epub ahead of print)Google Scholar
  25. 25.
    Winner B, Geyer M, Couillard-Despres S, Aigner R, Bogdahn U, Aigner L, Kuhn G, Winkler J (2006) Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol 197:113–121PubMedGoogle Scholar
  26. 26.
    Wolfensberger M, Schnieper I, Welge- Lussen A (2000) "Sniffin' Sticks": a new olfactory test battery. Acta Otolaryngol 120:303–306PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff-Verlag 2008

Authors and Affiliations

  • B. Herting
    • 1
  • S. Schulze
    • 1
  • H. Reichmann
    • 1
  • A. Haehner
    • 1
    • 2
  • T. Hummel
    • 2
  1. 1.Dept. of NeurologyUniversity of Dresden Medical SchoolDresdenGermany
  2. 2.Smell & Taste ClinicDept. of Otorhinolaryngology University of Dresden Medical SchoolDresdenGermany

Personalised recommendations